Viney Joanne L. 4
4 · Harpoon Therapeutics, Inc. · Filed May 7, 2021
Insider Transaction Report
Form 4
Viney Joanne L.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 totalExercise: $22.50Exp: 2031-05-03→ Common Stock (10,167 underlying) - Award
Director Stock Option (Right to Buy)
2021-05-04+2,653→ 2,653 totalExercise: $22.50Exp: 2031-05-03→ Common Stock (2,653 underlying)
Footnotes (2)
- [F1]The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date.
- [F2]50% of the shares subject to the option are fully vested and exercisable, and 25% will vest and become exercisable on September 30, 2021 and December 31, 2021, subject to the continuous service of the Reporting Person on each vesting date.